Clinicopathological patterns of drug-induced liver disease

Research output: Chapter in Book/Report/Conference proceedingChapter

5 Citations (Scopus)

Abstract

I. INTRODUCTION The liver ranks high on the list of targets affected by adverse reactions to therapeutic or environmental agents (1-3). Therefore, detection of hepatic abnormalities receives considerable attention during testing and following release of new agents. Awareness of druginduced reactions affecting the liver has become increasingly a matter of concern and searches have intensified for more effective ways to identify drugs that are likely to cause liver injury as well as subsets of patients who are at increased risk.

Original languageEnglish (US)
Title of host publicationDrug-Induced Liver Disease
PublisherCRC Press
Pages227-242
Number of pages16
ISBN (Electronic)9780203909126
ISBN (Print)9780824708115
StatePublished - Jan 1 2002

Fingerprint

Chemical and Drug Induced Liver Injury
Liver
Wounds and Injuries
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Maddrey, W. C. (2002). Clinicopathological patterns of drug-induced liver disease. In Drug-Induced Liver Disease (pp. 227-242). CRC Press.

Clinicopathological patterns of drug-induced liver disease. / Maddrey, Willis C.

Drug-Induced Liver Disease. CRC Press, 2002. p. 227-242.

Research output: Chapter in Book/Report/Conference proceedingChapter

Maddrey, WC 2002, Clinicopathological patterns of drug-induced liver disease. in Drug-Induced Liver Disease. CRC Press, pp. 227-242.
Maddrey WC. Clinicopathological patterns of drug-induced liver disease. In Drug-Induced Liver Disease. CRC Press. 2002. p. 227-242
Maddrey, Willis C. / Clinicopathological patterns of drug-induced liver disease. Drug-Induced Liver Disease. CRC Press, 2002. pp. 227-242
@inbook{62e84797c1b2439f83488a3ce4ec4ecc,
title = "Clinicopathological patterns of drug-induced liver disease",
abstract = "I. INTRODUCTION The liver ranks high on the list of targets affected by adverse reactions to therapeutic or environmental agents (1-3). Therefore, detection of hepatic abnormalities receives considerable attention during testing and following release of new agents. Awareness of druginduced reactions affecting the liver has become increasingly a matter of concern and searches have intensified for more effective ways to identify drugs that are likely to cause liver injury as well as subsets of patients who are at increased risk.",
author = "Maddrey, {Willis C}",
year = "2002",
month = "1",
day = "1",
language = "English (US)",
isbn = "9780824708115",
pages = "227--242",
booktitle = "Drug-Induced Liver Disease",
publisher = "CRC Press",

}

TY - CHAP

T1 - Clinicopathological patterns of drug-induced liver disease

AU - Maddrey, Willis C

PY - 2002/1/1

Y1 - 2002/1/1

N2 - I. INTRODUCTION The liver ranks high on the list of targets affected by adverse reactions to therapeutic or environmental agents (1-3). Therefore, detection of hepatic abnormalities receives considerable attention during testing and following release of new agents. Awareness of druginduced reactions affecting the liver has become increasingly a matter of concern and searches have intensified for more effective ways to identify drugs that are likely to cause liver injury as well as subsets of patients who are at increased risk.

AB - I. INTRODUCTION The liver ranks high on the list of targets affected by adverse reactions to therapeutic or environmental agents (1-3). Therefore, detection of hepatic abnormalities receives considerable attention during testing and following release of new agents. Awareness of druginduced reactions affecting the liver has become increasingly a matter of concern and searches have intensified for more effective ways to identify drugs that are likely to cause liver injury as well as subsets of patients who are at increased risk.

UR - http://www.scopus.com/inward/record.url?scp=15444376961&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=15444376961&partnerID=8YFLogxK

M3 - Chapter

SN - 9780824708115

SP - 227

EP - 242

BT - Drug-Induced Liver Disease

PB - CRC Press

ER -